Novavax COVID-19 Vaccine Able To Successfully Trigger Immune Response

In a promising development, an early-stage clinical trial of the Novavax COVID-19 vaccine has shown that it can successfully trigger an immune response. Watch this video to find out more about the Novavax vaccine and what the US pharma company plans to do before the vaccine can be mass-produced.